# OnCo record nct07213882 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07213882/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07213882", "NCT07213882" ;
  schema:name "A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)"@en ;
  schema:description "A phase 1 trial of DT-7012 run by Assistance Publique - Hôpitaux de Paris, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07213882/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07213882> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/mycosis-fungoides/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/dt-7012/> ;
  onco:companies <https://onco.cc/companies/domain-therapeutics/> .